In connection with entering into the Employment Agreement, Mr. Knag will be granted two awards under the Company’s 2021 Incentive Award Plan (the “2021 Plan”): (i) an award of 145,000 restricted stock units (the “RSU Award”) and (ii) an Other Cash or Stock-Based Award (as defined in the 2021 Plan) pursuant to the Company’s long-term incentive program (the “LTIP Award”). The material terms and conditions of these awards are described below in the section titled “Equity Awards under 2021 Plan.”
In addition, Mr. Knag is eligible to receive equity-based compensation awards as determined by the Board (or a subcommittee thereof) from time to time. Mr. Knag is also eligible to participate in the health and welfare benefit plans and programs maintained by us for the benefit of our employees, as well as the paid-time-off programs maintained by us for the benefit of our executives generally.
In connection with his appointment, Mr. Knag has agreed to relocate to the greater Phoenix area by October 1, 2024. The Company will pay to Mr. Knag $100,000 in a lump-sum cash payment for any reasonable and necessary relocation and moving expenses that Mr. Knag incurs in connection with his move. Mr. Knag will be required to repay this amount to the Company in the event that (i) Mr. Knag’s employment with the Company is terminated by the Company for “cause” (as defined in the Employment Agreement) or by Mr. Knag for any reason, in any case, on or within the 12-month period immediately following the date on which Mr. Knag relocates; or (ii) Mr. Knag has not relocated to the greater Phoenix area on or prior to October 1, 2024.
Under the Employment Agreement, on a termination of Mr. Knag’s employment by the Company without “cause”, by Mr. Knag for “good reason” (as defined in the Employment Agreement) or by reason of a non-renewal of the term by the Company (each, a “Qualifying Termination”), he is eligible to receive the following severance payments and benefits:
(i) (A) an amount equal to his then-current annual base salary, payable in substantially equal installments in accordance with the Company’s normal payroll practices over 12 months following the date of termination; or (B) if such Qualifying Termination occurs within the period commencing three months prior to and ending one year following the date on which a Change in Control (as defined in the 2021 Plan) is consummated (a “CIC Termination”), an amount equal to the sum of his then current base salary and target bonus, generally payable in installments over 12 months following the date of termination or, if the CIC Termination occurs on or within one year following the Change in Control, in a single lump sum within 30 days following the date of termination;
(ii) if such Qualifying Termination is a CIC Termination, an amount equal to the pro-rata portion of his annual bonus that would have otherwise been earned for the year in which the termination occurs (determined in accordance with the Employment Agreement and pro-rated based on the number of days Mr. Knag was employed by the Company during such year), payable no later than March 15 of the year following the year in which the termination occurs;
(iii) Company-paid healthcare coverage and life insurance for up to 12 months following the date of termination; and
(iv) if such Qualifying Termination is a CIC Termination, any then-outstanding unvested Company equity compensation award that vests solely based on time shall become fully vested on an accelerated basis as of the date of termination (or upon the Change in Control, if later), and any equity compensation awards that are subject to performance conditions shall be treated in accordance with the terms and conditions set forth in the applicable award agreement.
The eligibility of Mr. Knag to receive such severance payments and benefits upon a Qualifying Termination, as described above, is subject to his timely execution and non-revocation of a general release of claims in favor of the Company and continued compliance with restrictive covenants.
In addition, the Employment Agreement contains customary confidentiality and assignment of inventions provisions, as well as (i) standard non-compete and service provider/customer non-solicitation restrictions effective